These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33601052)

  • 1. Centyrin ligands for extrahepatic delivery of siRNA.
    Klein D; Goldberg S; Theile CS; Dambra R; Haskell K; Kuhar E; Lin T; Parmar R; Manoharan M; Richter M; Wu M; Mendrola Zarazowski J; Jadhav V; Maier MA; Sepp-Lorenzino L; O'Neil K; Dudkin V
    Mol Ther; 2021 Jun; 29(6):2053-2066. PubMed ID: 33601052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of siRNA payloads to target KRAS-mutant cancer.
    Yuan TL; Fellmann C; Lee CS; Ritchie CD; Thapar V; Lee LC; Hsu DJ; Grace D; Carver JO; Zuber J; Luo J; McCormick F; Lowe SW
    Cancer Discov; 2014 Oct; 4(10):1182-1197. PubMed ID: 25100204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.
    He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A
    Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin.
    Ganesh S; Koser ML; Cyr WA; Chopda GR; Tao J; Shui X; Ying B; Chen D; Pandya P; Chipumuro E; Siddiquee Z; Craig K; Lai C; Dudek H; Monga SP; Wang W; Brown BD; Abrams MT
    Mol Cancer Ther; 2016 Sep; 15(9):2143-54. PubMed ID: 27390343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.
    McNamara JO; Andrechek ER; Wang Y; Viles KD; Rempel RE; Gilboa E; Sullenger BA; Giangrande PH
    Nat Biotechnol; 2006 Aug; 24(8):1005-15. PubMed ID: 16823371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
    Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
    Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
    Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and validation of structurally defined antibody-siRNA conjugates.
    Nanna AR; Kel'in AV; Theile C; Pierson JM; Voo ZX; Garg A; Nair JK; Maier MA; Fitzgerald K; Rader C
    Nucleic Acids Res; 2020 Jun; 48(10):5281-5293. PubMed ID: 32347936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.
    Dudek H; Wong DH; Arvan R; Shah A; Wortham K; Ying B; Diwanji R; Zhou W; Holmes B; Yang H; Cyr WA; Zhou Y; Shah A; Farkiwala R; Lee M; Li Y; Rettig GR; Collingwood MA; Basu SK; Behlke MA; Brown BD
    Mol Ther; 2014 Jan; 22(1):92-101. PubMed ID: 24089139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EpCAM-targeted liposomal si-RNA delivery for treatment of epithelial cancer.
    Bhavsar D; Subramanian K; Sethuraman S; Krishnan UM
    Drug Deliv; 2016 May; 23(4):1101-14. PubMed ID: 25417832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
    Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
    Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab-siRNA Conjugate Linked Through Cationized Gelatin Knocks Down KRAS G12C Mutation in NSCLC Sensitizing the Cells Toward Gefitinib.
    Sreedurgalakshmi K; Srikar R; Harikrishnan K; Srinivasan L; Rajkumari R
    Technol Cancer Res Treat; 2021; 20():15330338211041453. PubMed ID: 34542333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-EpCAM-conjugated adeno-associated virus serotype 2 for systemic delivery of EGFR shRNA: Its retargeting and antitumor effects on OVCAR3 ovarian cancer in vivo.
    Lee S; Ahn HJ
    Acta Biomater; 2019 Jun; 91():258-269. PubMed ID: 31026519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Centyrin-Based Near-Infrared Probe for Fluorescence-Guided Surgery of Epidermal Growth Factor Receptor Positive Tumors.
    Mahalingam SM; Dudkin VY; Goldberg S; Klein D; Yi F; Singhal S; O'Neil KT; Low PS
    Bioconjug Chem; 2017 Nov; 28(11):2865-2873. PubMed ID: 28945346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi).
    Xiang S; Keates AC; Fruehauf J; Yang Y; Guo H; Nguyen T; Li CJ
    Methods Mol Biol; 2009; 487():147-60. PubMed ID: 19301646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor gene by shRNA-expressing Salmonella-mediated RNAi.
    Guo H; Zhang J; Inal C; Nguyen T; Fruehauf JH; Keates AC; Li CJ
    Gene Ther; 2011 Jan; 18(1):95-105. PubMed ID: 20811467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simplified and versatile system for the simultaneous expression of multiple siRNAs in mammalian cells using Gibson DNA Assembly.
    Deng F; Chen X; Liao Z; Yan Z; Wang Z; Deng Y; Zhang Q; Zhang Z; Ye J; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Li M; Geng N; Zhao L; Zhou G; Zhang P; Luu HH; Haydon RC; Reid RR; Yang T; He TC
    PLoS One; 2014; 9(11):e113064. PubMed ID: 25398142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of β-catenin gene silencing by shRNA on biologic characteristics of human esophageal carcinoma cells].
    Wang JS; Ji AF; Wen JF; Ren HZ
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):835-41. PubMed ID: 21215100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobody-siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells.
    Zavoiura O; Brunner B; Casteels P; Zimmermann L; Ozog M; Boutton C; Helms MW; Wagenaar T; Adam V; Peterka J; Metz-Weidmann C; Deschaght P; Scheidler S; Jahn-Hofmann K
    Mol Pharm; 2021 Mar; 18(3):1048-1060. PubMed ID: 33444501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.